Alexandra Goll

Alexandra Goll

Direttore/Membro del Consiglio presso
Biovertis AG
70 anni
Health Technology
Finance
Consumer Services

Profilo

Ms. Alexandra Goll is General Partner at TVM Capital GmbH which she joined in 1998.
She is also Mitglied des Vorstands at Addex Pharmaceuticals SA. She is on the Board of Directors at Biovertis AG, Arrow Therapeutics Ltd., Cerenis Therapeutics Holding SA, and Albireo AB. Dr. Goll also served on the board at Pharmasset, Inc. Prior to her affiliation with TVM, Dr. Goll was the Global Business Leader for HIV and CMV, and was responsible for strategic marketing and business development for Virology at Roche Ltd. in Basel.
She had been involved in clinical development and managing commercialisation strategies of several products.
Dr. Alexandra Goll holds a degree in pharmacy from the Free University of Berlin, and wrote her doctoral dissertation in natural sciences at Philipps University of Marburg.

Posizioni attive di Alexandra Goll

SocietàPosizioneInizio
Direttore/Membro del Consiglio -

Precedenti posizioni note di Alexandra Goll

SocietàPosizioneFine
HEIDELBERG PHARMA AG Direttore/Membro del Consiglio 14/12/2011
ADDEX THERAPEUTICS LTD Corporate Officer/Principal 17/04/2008
Direttore/Membro del Consiglio 02/11/2007
IDENIX PHARMACEUTICALS INC Direttore/Membro del Consiglio 01/05/2003
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Alexandra Goll

Formazione di Alexandra Goll

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

33

Relazioni di 1° grado

13

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private13

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Alexandra Goll